FS-021

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFS-021
Drug Alias NameFcab (f-star)FS-021
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionAngiogenesis modulators
TargetsUpdating
Therapy Area/IndicationsAngiogenesis disorderNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF-Star Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF-Star Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A